Test, Tricyclic Antidepressant Drugs, Employment And Insurance Testing, Exempt

Device Code: 6272

Product Code(s): PVK

Definition: The Tricyclic Antidepressant Drugs Test Is An In Vitro Diagnostic Test For The Qualitative Analysis Of Tricyclic Antidepressant Drugs For Employment And Insurance Testing. FDA Has Exempted These Devices From The Premarket Notification Requirement By

Device Classification Information

Device Type ID6272
Device NameTest, Tricyclic Antidepressant Drugs, Employment And Insurance Testing, Exempt
Physical StateIn Vitro Diagnostic Device
Technical MethodImmunoassay
Target AreaIn Vitro Specimen
Regulation DescriptionTricyclic Antidepressant Drugs Test System.
Regulation Medical SpecialtyToxicology
Review PanelToxicology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(K) Exempt
CFR Regulation Number862.3910 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodePVK
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID6272
DeviceTest, Tricyclic Antidepressant Drugs, Employment And Insurance Testing, Exempt
Product CodePVK
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionTricyclic Antidepressant Drugs Test System.
CFR Regulation Number862.3910 [🔎]
TPLC Last Update: 2019-04-02 21:19:41

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.